We have already started planning of the events for 2017. We keep you updated and add details on dates and topics. Let’s go towards better learning in 2017! https://algolpharma.fi/pharmaceutical-services/training-services/
Algol Oy has sold its wholly-owned subsidiary Algol Pharma Oy to Biocodex S.A.S., a multinational specialty pharmaceutical company based in Paris, France. The divestment has been completed on September 9th. In future, the Algol Group will focus on business areas within the fields of chemicals and raw materials, technical products, maintenance and solutions as well as healthcare technology.
“What medications do you use and in what doses?” “I used the medicine for 3 months, but it gave me strange hot flashes. My pulse would rise and I would feel anxious. At times it felt like I would pass out. I don’t recommend it to anyone.” “You can safely increase the dose considerably from what’s written on the package. For many users the medicine only begins to work after doubling the dose.”
Finlandhealth.fi represents the entire Finnish health care sector’s know-how through one digital portal and presents a comprehensive view and specific set of health care offerings from Finland. The website can be found at http://www.finlandhealth.fi/ a
”After Bayer started using the online course the performance monitoring has been automated and the pharmacovigilance department is now up to date on the reach of the pharmacovigilance training throughout the organization.” Mia Tolonen, Bayer Read more:
We have started to provide Good Pharmacovigilance Practices (GVP) Training webinars for Pharma companies. You are warmly welcome to join our first GVP Training session on Module I The webinar will take place on 31st of March at 13.00 – 14
In Baltic States – Estonia/Latvia/Lithuania there will be changes in electronic submission requirements in line with the HMA eSubmission Roadmap. From January 1st, 2016 it will be mandatory to use electronic application form for all procedures (human a
How could we help you in one or several of the following fields: regulatory services translations pharmacovigilance (local drug safety officer) GMP, GDP and PV audits approving of marketing materials trainings For more information contact Director of P
Algol Pharma Oy has signed an agreement with Tillotts Pharma AB the concerning distribution and marketing of ASACOL® products in the Baltic States. ASACOL® (active ingredient: mesalazine) is an anti-inflammatory drug used to treat inflammatory bowel di
The training session will give you and update of current issues, challenges and opportunities in Pharmacovigilance and Drug Regulatory Affairs in local (Estonia, Latvia and Lithuania) and EU level as well as New Good Distribution Practices -guideline and internal audits.
Algol Pharma AB is a new responsible for sales and marketing of StopHémo product in Sweden towards the pharmacy-channel. StopHémo helps to stop nosebleeding and improves heeling. Product is manufactured by an independent French pharmaceutical laborato